期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Diabetes Metabolic Syndrome and Obesity LetPub Score 6.2
50 ratings
Rate
Reputation 7.2 Influence 5.2 Speed 7.1 | ||||||||||||||||||||
期刊簡稱 | DIABET METAB SYND OB | ||||||||||||||||||||
ISSN | 1178-7007 | ||||||||||||||||||||
h-index | 35 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 3.60%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal | ||||||||||||||||||||
在線稿件提交 | https://www.dovepress.com/submit_step_1.php | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Dove Medical Press Ltd. | ||||||||||||||||||||
主題領域 | Pharmacology, Toxicology and Pharmaceutics | ||||||||||||||||||||
出版國/地區 | New Zealand | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 337每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 98.74% | ||||||||||||||||||||
OA Related Info | APC: Yes( USD3300; ) APC waiver:Check Notes Other charges: No Keywords: diabetes、obesity、metabolic syndrome Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7007%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 16 Weeks | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Diabetes Metabolic Syndrome and Obesity] 的評論 | 撰寫評論 |
作者: 鱼慧蛋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-08 12:32:17 評論於 May I ask, how long did it take for the publication to be released after being hired? Thank you~~(0) 讚! | 鱼慧蛋 |
作者: 扶昇 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-07-24 11:16:11 評論於 This is a small niche journal with a low impact factor, mainly focusing on papers related to diabetes, metabolic diseases, and obesity. Manuscripts submitted at the end of March will start the external review process at the end of May. The journal requires two reviewers, but it wasn't until early July that the two reviewers were found. After that, the manuscript went to the editor, who decided a week later that revisions were needed. Authors were given 2-3 weeks to make revisions, with the option to request an extension by emailing the editorial department. The revised manuscript was sent back a little over a week later and was accepted after a few days. Overall, it is a very user-friendly journal, as authors are notified via email of every status change in their manuscript. They are quite attentive to the authors' needs.(0) 讚! | 扶昇 |
作者: grace萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-12 09:08:40 評論於 Do I need to pay in advance?(0) 讚! | grace萍 |
作者: 呵呵呵 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-08-31 10:53:17 評論於 The review process was very fast. Three weeks after submission, reviewers were assigned. Two reviewers were invited, and their comments were very professional. After minor revisions submitted in two weeks, the editorial assistant raised a few questions. The manuscript went through four more rounds of revisions over the course of a month, showing great attention to detail by the assistant. Thumbs up! Finally, the paper was accepted for publication, taking about three months from submission to acceptance. Best wishes to all researchers for their success!(2) 讚! | 呵呵呵 |
作者: hmily1527 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-12 10:11:34 評論於 Ah, what is the subject of the article? How far along is it in the peer-review process? I just submitted it and suddenly became afraid.(0) 讚! | hmily1527 |
作者: apoptoxin4869 領域: 医学 審稿時間: 6.0 month(s) 結果: 拒稿 撰寫評論 |
2022-07-11 09:05:01 評論於 The submission was rejected after more than a month, with the reason being unable to find enough peer reviewers... It's quite unreasonable.(0) 讚! | apoptoxin4869 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us